Intellisphere Takes Docs to the Web

New in Town: MediMax

Expansions: Cytocom

Pharma Ad Agency CDM Expands

Korean Pharma Expands at Carnegie

Japanese Pharmas New in Town

Leaving Town

Health Expansion

Expansions: CRO Clinphone

New in Town CRO Esoterix

Crosstown Moves

Down-Sizing

Deaths

Corrections or additions?

This article by Barbara Fox was prepared for the December 4, 2002 edition of U.S. 1 Newspaper. All rights reserved.

Healthcare on the Move: MultiMedia Healthcare/Freedom

Robert Preston, the new CEO of MultiMedia Healthcare/Freedom

at Princeton Meadows Office Center, has introduced a free magazine

now being distributed at 4,100 CVS pharmacies nationwide. With the

title "Family Health Matters: A Woman’s Guide to Family Medicine,"

this quarterly magazine aims to reach the lucrative women’s market.

Women make 75 percent of the healthcare decisions in the United States,

according to one recent study, and women spend nearly two out of every

three healthcare dollars. Preston says that the nearly 1 million copies

of this new magazine — the first consumer publication to focus

on gender-specific health — could reach up to 35 million customers

each month. Each issue features a specific health topic that affects

women and their families, from bone and heart health to aging and

stress management.

"This is an opportunity to diversify our revenue — we are

going after the direct-to-patient consumer bucket," says Preston.

"Our focus is to become insulated from the ups and downs of journal

advertising and become more dependent on medical education dollars.

Most medical publishing companies are doing both. Everybody is trying

to get a piece of this money because it seems to be endless. Clients

may not have journal advertising money but they always have medical

education money."

"We knew the market was out there, and we are securing the distribution

through CVS. This aligns with the CVS business model that the female

is making more of the health related decisions — their stores

are set up for women," says Preston.

"How we try to distinguish ourselves," says Preston, "is

with credentialized marketing. Every medical education piece we put

out, every journal article, is associated with a leading association

or institution." American Family Health Matters, for instance,

"has content that readers can trust because it’s backed by the

authority of Columbia University, a world-class institution."

The editor is Marianne J. Legato MD, founder of the Partnership for

Gender-Specific Medicine and a professor at Columbia.

"The changing medical landscape is making women’s lives more complicated

than ever," Legato says. "Our goal is to arm women with the

information they need to make educated decisions — for themselves

and for their families."

Preston majored in business at Montclair State, Class of 1977, and

started out selling ad space for the Patterson News. He has been in

healthcare publishing for more than two decades. Before taking this

job he had been group publisher in Montvale for Medical Economics

Thomson Healthcare.

Marjorie Schulz is editorial director for the company, a division

of Freedom Magazines, that also publishes the Journal of Gender-Specific

Medicine, a peer-reviewed journal that is the official publication

of the Partnership for Gender-Specific Medicine at Columbia. Its other

publications are Clinical Geriatrics, the Annals of Long-Term Care,

and Home Health Care Consultant. In addition it sponsors meetings

and other medical education programs for health care professionals.

A billion dollar, privately held firm, Freedom’s flagship publication

is the Orange County Register, and it has other daily and weekly newspapers

plus eight television stations. Last year it exercised an option to

buy all of Multimedia Healthcare (U.S. 1, March 20). Since then Multimedia

Healthcare has grown from 23 to 29 employees at this location.

Warren A. Dardine, president of the Pennsylvania-based Programs In

Medicine, was in charge of launching this magazine project. The launch

issue was just 20 pages, says Dardine, and he expects it to grow to

32 pages. A 1976 graduate of Weidner University, he did graduate work

at Penn medical school and then worked in marketing for Wyeth and

an ad agency. "We wanted to secure a minimum number of advertisers

and introduce it as a highly credentialed publication. There was high

interest but we were moving rather rapidly. I can’t tell you

how many contacts we made and those contacts are now coming through,"

says Dardine.

Multimedia Healthcare/Freedom LLC, 666 Plainsboro

Road, Suite 440, Plainsboro 08536. Robert Preston, CEO. 609-275-3800;

fax, 609-716-8138. Home page: www.mmhc.com

Top Of Page
Intellisphere Takes Docs to the Web

Intellisphere, the medical education company that focuses

on explaining the Internet to doctors, and that once was a part of

Multimedia Healthcare, thinks that doctors are moving to the "point

of sale" mentality. Instead of browsing a medical journal for

articles that catch their eye, they are doing more targeted research

on the Internet.

"The readership among highly clinical journals is starting to

flatten and trail off," says Herb Marek, COO of Intellisphere.

"Doctors are going to Medline or one of the other good medical

sites to get information on a particular disease in a particular demographic

and going right to the article."

Intellisphere publishes MD Net Guide, Oncology Net Guide, and Family

Medicine Net Guide, and it has just spun off eight specialty publications

— for cardiology, endocrinology, respiratory, gastroenterology,

psychiatry, neurology, and rheumatology.

"We try to enhance the physician’s knowledge of how to use the

hardware and software to get the best out of the Internet and provide

the direct links to the best medical education and clinical information

sites," says Marek. A graduate of Kean College, he has master’s

degrees from Rutgers and Fairleigh Dickinson. He stayed with Intellisphere

when the company split, with half going to Multimedia Healthcare/Freedom

LLC (see article above) and Michael Hennessey owning the Intellisphere

half (U.S. 1, March 20).

"We tested the waters and will have four issues of Family Net

Guide next year," says Marek. "We scour the net for new medical

content, our editorial board evaluates it, and it ends up in our journal."

Clinical and practice management information comprise 90 percent of

the content, and leisure links (those ads for sailboats and luxury

cars) just 10 percent. This information is also available online (for

easy clicking through) and on E-mail newsletters but print ads are

the cash cows of the publishing business, he admits. "Our online

versions provide added value to our advertisers."

The proof of success is in the page numbers. The September issue for

primary care physicians was 54 pages, and the specialty magazines

are 32-36 pages. To put this in perspective, the medical information

industry is down 13 percent in pages, in the year to date, yet even

taking into account the fact that Intellisphere operates from a relatively

small baseline, its page count is up 50 percent.

Intellisphere, 666 Plainsboro Road, Suite 300,

Plainsboro 08536. Michael Hennessey, CEO. 609-716-7777; fax, 609-716-4747.

Home page: www.mdnetguide.com

Top Of Page
New in Town: MediMax

MediMax Communications Inc. plans medical initiatives

for pharmaceutical companies. Based in Durham (its first major client

is a pharmaceutical company in the Research Triangle), it has nine

employees. Partners Staci Cunliffe and Joanne Rosenberg founded the

company in 1999 and opened the Carnegie Center office in September.

"We moved to Princeton because we are trying to expand our northeast

business, and this is the pharmaceutical hub," says Rosenberg.

Cunliffe went to the University of Nebraska, Class of 1990, and did

social work in England for two years, then worked for a not-for-profit

doing grant writing, business development, and educational programs.

Ten years ago she moved to a medical education field for major clinical

research organizations.

A native of Jackson, New Jersey, Rosenberg went to State University

of New York at Downstate Medical Center in Brooklyn, where she learned

to perform to be a sonographer (performing high risk ultrasounds).

"Part of my job was planning medical meetings, and I decided that’s

what I love to do," she says. "We are strategic partners with

pharmaceutical companies to plan strategic medical initiatives in

different therapeutic areas. When they have a drug coming to market,

we help them plan initiatives around the launch of that drug. To educate

physicians, we do anything from journal supplements to arranging

a teleconference series, creating advisory boards, and holding speaker

training meetings."

"Because we come from medical and human services backgrounds,

we have more of a scientific spin to our peer development programs

and our strategic thinking, versus the advertising approach,"

says Cunliffe. "Every person on the account team must do a tutorial

on the therapeutic area and the products related to the treatment

of the disease, so that they have a knowledge base. We are the eyes

and ears for the client."

MediMax Communications Inc., 212 Carnegie Center,

Carnegie Executive Center, Suite 206A, Princeton 08540. 609-919-6330;

fax, 609-520-1806. Stacy Cunliffe and Joanne Rosenberg, partners.

E-mail: sales@medimaxcom.net.

Top Of Page
Expansions: Cytocom

This full service, international healthcare communication

company moved from Forrestal Village to Clarksville Road, where it

has 18 employees. It had been purchased by Rose Worldwide, a holding

company that is in turn owned by Habas, the fifth largest advertising

and communications company in the world.

Among the Rose Worldwide companies are an advertising firm, Robert

A. Becker, and a medical education company in Trevose, Pennsylvania.

For major pharmaceutical corporations, Cytocom offers business strategy,

communications for current and new products, medical education, medical

writing, and publications. Clients include Amgen, Sanofi-Synthelabo,

Pharmacia, Centocor, and Wyeth.

After 11 years experience in the pharmaceutical industry, Gordon Beck

started his company in his home, and he named it after the word for

cell plus com for communications. A bachelor and a 1985 graduate of

the University of Kansas, he lives in Princeton in Bainbridge Estates.

His father worked for the Army as director of a hospital, and his

mother was a pharmacist.

Beck worked at Hoffman LaRoche and then at Bristol-Myers Squibb, where

he directed cardiovascular marketing, before joining a medical education

company (Medicus Worldwide Group in Manhattan) as president and managing

director of Science and Medicine. A bachelor, he lives in Princeton

in Bainbridge Estates.

"After my Science and Medicine tenure, I had some good client

relationships and decided to try to translate that into a business,"

says Beck, who expects to have $10 million in billings this year.

Cytocom, 231 Clarksville Road, Suite 1, West Windsor

08550-1505. Gordon Beck, managing director. 609-378-2600; fax, 609-378-2610.

Home page: www.cytocom.com

Top Of Page
Pharma Ad Agency CDM Expands

After two years the Princeton office of the ad agency

that did the Viagra/Bob Dole commercial — CDM — has expanded

from 214 Carnegie Center to bigger quarters at 302 Carnegie. The phone

and fax are new. Headquartered in Manhattan at East 22nd Street, the

firm focuses on the pharmaceutical industry. Among its accounts are

Bristol-Myers Squibb, Wyeth, Janssen Pharmaceutica, and Johnson &

Johnson. It has another office in Red Bank and has 350 workers overall.

The managing partners are Ashley Schofield (creative director-art),

Kyle Barich (director client services) and Gerard McLaughlin (creative

director-copy).

CDM at Princeton, 302 Carnegie Center, Suite 102,

Princeton 08540. Kyle Barich, director of client services. 609-716-4400.

Home page: www.clinedavis.com

Top Of Page
Korean Pharma Expands at Carnegie

The pharmaceutical division of the largest food manufacturer

in Korea has moved into the Carnegie Center, where it plans to add

up to 25 people to its current five-person staff.

"Our plan to expand R&D in North America will require significant

growth," says Andrew Gorman, vice president and chief of business

development of CJ Pharma. "In Princeton we will be adding people

primarily in sales and marketing, regulatory, market research, project

management, clinical development, and logistics." Though CJ Pharma

is classified as a pharmaceutical company, it will outsource many

elements — patent and contract law, financial analysis, human

resources, and market research.

Current quarters are 3,400 square feet. "We will keep expanding

at the Carnegie Center but are very open to alternative space that

fits our needs," says Jong H. Kim, CJ’s global commercial director.

"We picked the Princeton area as a hub for the east coast. Since

we are also searching for biotech and other alliances, it puts us

in a very strategic location." The sales and marketing office

is in Fort Lee.

"Our main focus is to develop additional therapeutic indications

for proprietary drugs in regulated markets," says Kim. New products

to be acquired from outside sources might include specialized therapeutic

areas such as anti-infectives, products with patents that might be

extended with new formulations and indications, and hospital-based

products for acute care. "We feel that, with a smaller sales force,

we can gain more profitability in a hospital segment," says Kim.

The company aims to increase revenues significantly — doubling

or tripling sales by 2007 with higher than average profitability.

"We anticipate initiating our first sales by third quarter 2003,"

says Gorman. "By 2007 our global target for the division as a

whole is $500 to $600 million or $250 million from this office. Last

year division sales were $165 million, and this year we are targeting

$200 million, including Korea and worldwide."

CJ Pharma’s Chairman H. Lee, who spent 30 years in the United States

with Unilever, has what Kim calls "a Western way of thinking."

The head of R&D has a similar background. Kim says the company recognizes

that in order to grow its pharma business, it has to acknowledge the

western view of doing business.

Kim and Gorman attend investment meetings, have met with representatives

of various programs offered by the state, and have talked with some

of the incubator programs and small business grant programs. "Although

we are part of a conglomerate, we view ourself as having an opportunity

to grow through seed funding from various sources to help us fund

special projects," says Gorman. CJ went to Bristol-Myers Squibb

to get Gorman.

"It was a bold move to hire an American," admits Gorman. "The

company recognized that there needed to be some perspective that might

not be present in CJ Pharma. We have now a blend of Korean expertise

as well as U.S. and European expertise. Mr. Kim represents a nice

blend of expertise — Latin America and the Middle East as well

as Korea. And I bring a blend of expertise in addition to North America."

Gorman went to Baylor University and took his PhD in pharmacology

and physiology at the University of Texas at San Antonio. He did postdoctoral

work at Northwestern Memorial in Chicago, taught at East Carolina

School of Medicine in Greenville, and went to Hoechst Roussel (now

Aventis) in 1990, where he was in charge of corporate business development

and licensing. In his last three years there he was responsible for

Japan, and he had also been in charge of North American and Europe.

In 1998 he moved to Bristol-Myers Squibb, and he came to CJ in April,

2001. He lives in Yardley with his wife, an interior decorator, and

they have two grown daughters.

Kim majored in organic chemistry at Korea University and did his master’s

degree at Oregon State in 1985. Then he worked as a research scientist

at Samsung Corp. and moved to the pharmaceutical division as sales

and marketing manager in 1994. When he came to the United States again

he worked in Fort Lee at CJ America, where he was general manager

for North and South America for the pharmaceutical division and opened

the market for Central and Latin America. One year ago he joined the

new firm, CJ Pharma, as director. Instead of moving to Fort Lee, an

enclave for expatriate Koreans, Kim and his wife and two school-aged

children chose to settle in Paramus.

"We will continue to hire Americans with key expertise in the

United States and Europe, making sure we keep the culture of Korea

intact," says Gorman.

Gorman’s job is to leverage the strengths of both business cultures.

"One of the challenges we have in being a hybrid global Korean

company is to reach a nice blend of keeping the positive aspect of

being a Korean company but also meeting the dynamics of the way that

U.S. and European companies like to operate. That is the one area

in which I am trying to initiate change."

"Korean people are very hard working and very dedicated, to company

and family and culture," Gorman says. "One of the striking

things is that the culture is very homogenuous, not only in Korea

itself but also in clusters in the United States. That is something

that needs to be recognized and respected. In doing business in Korea,

consensus building is important and decisions are made only after

getting to know the product, customer, and the partner."

Says Gorman: "Obtaining products and being a good strategic partner

requires sense of urgency and dedication, but we also have to respect

the process and culture of consensus building."

One way to convey urgency is to start the work week promptly. Because

Korea has a 14-hour time difference, that means that Gorman and Kim

start making phone calls on Sunday evening. Says Gorman: "To try

to reach a blend of timely decision making, we need to be sure all

our colleagues in Korea understand the opportunity as well as we do."

"With its long history, CJ Corporation is a leading Korean company

and is highly recognized in Korea and southeast Asia," says Kim.

"Korea represents one percent of the worldwide pharmaceutical

market. This is the only pharmaceutical office that we know of from

Korea that was established in the United States with global responsibilities."

CJ stands for the original company name Cheil Jedang.

Translated, that means premiere sugar manufacturer. The Byung Chul

Lee family started a sugar refinery business after the Korean War.

From there the company diversified into heavy industry, electronics,

ship building, and consumer products such as clothing, so that now

it has more than 36 different subsidiaries. In 1987 the founder died,

and CJ divested out of the Samsung group, which focuses on electronics

and heavy industry. The pharmaceutical division was created in 1984

and made a separate company in 2001.

"Our brand name has had a very good reputation for the past 50

years in the domestic market, and we have 10,000 consumer products,"

says Kim. "Now we want to globalize it, and CJ is easy to understand

and read."

CJ already had a strong domestic business, but it wanted to grow,

not just by getting new products but also by getting a piece of regulated

markets like North American and Europe. "CJ will be a specialty

pharmaceutical, obtaining products from partnering and strategic agreements,

obtaining products from worldwide sources for South America and southeast

Asia. We are in the process of building a portfolio of branded products

and branded generics products," says Gorman.

"We tried to bring our products from Korea to the United States,"

says Kim, "but the Food and Drug Administration is a big barrier

to an Asian company. We wanted to commercialize products quickly,

so we went to an unregulated market such as Latin America. In five

years our sales grew to $20 million, but there is a lot of competition

from India and China. When the market becomes crowded, we don’t see

any value there."

In an unregulated market, most of the business involves bidding against

competitors for a country’s contract. "There is no requirement

for certified good manufacturing practices," says Kim. "Now

we want to compete in the regulated markets to gain limited exclusivity

and form alliances for FDA-approved production and manufacturing to

get premium pricing.

North America is not the company’s only target. For 40 to 50 years

CJ has had strong ties with Japanese pharmaceutical and food companies,

and it hopes to extend those ties to China. "Bulk production is

a big issue and China is becoming very prominent in that. We are looking

at some of the biotechnology that may be emerging from China,"

says Kim.

Gorman expects to identify some community activities and become more

closely associated with the state of New Jersey, as well as to do

R&D with Princeton University and Rutgers and encourage exchange programs

of scientists to and from Korea. Like most executives in Asian companies,

Gorman and Kim are avid golfers, so some of their networking will

take place out on the links.

CJ Pharma, 212 Carnegie Center, Suite 302, Princeton

08540. Andrew Gorman, vice president, chief business development officer.

609-897-0780; fax, 609-897-0725.

Top Of Page
Japanese Pharmas New in Town

Otsuka Pharmaceuticals, 100 Overlook Center, Third

Floor, Princeton 08540. Taro Iwamoto, global project manager. 609-452-2922;

fax, 609-452-1441. Home page: www.otsuka.com

Two sister Japanese firms, Otsuka Pharmaceuticals and

Taiho Pharmaceutical USA, have opened offices at Princeton Overlook.

Otsuka Pharmaceutical has a major partnership with Bristol-Myers Squibb

and it will have up to a dozen employees in this office. Otsuka will

concentrate on drugs for the central nervous system, and it is partnering

with B-MS on aripiprazole an investigational treatment for schizophrenia.

Headquartered in Tokyo, the company was founded by Busaburo Otsuka

and is one of the largest privately held companies in the world. Many

family members work for the firm, including the grandson of the founder.

Now Otsuka includes 32 companies and 19,000 employees, including 500

in the United States. Total revenues are more than $4.5 billion, and

products include nutraceuticals, "cosmedics," chemical ingredients,

daily necessities and household goods, food and drink products, and

products related to environment maintenance.

Otsuka started out in 1921 to develop intravenous solutions. Among

its consumer products now are food and nutraceuticals for quality

of life enhancements (fiber, sports drinks, and vitamins). Its first

consumer product, in 1965, was OramininC, a nutritional drink. In

1964 it began to focus more on pharmaceutical products, and it opened

a research facility in Rockville, Maryland, in 1985. Its products

include a partnership with Pfizer.

Taiho Pharma U.S.A. Inc., 100 Overlook Center,

Third Floor, Princeton 08540. Masayuki Kobayashi, president. 609-987-9339;

fax, 609-987-9332. Home page: www.taiho.co.jp

Taiho Pharma USA belongs to the family of Otsuka companies.

"Our mission is to bring our original anticancer drug to the patients

in the United States," says Masayuki Kobayashi, the president

of the United States division. He expects to have a total of 15 people

at this office, which moved from Manhattan this fall. Taiho is part

of the Otsuka group.

Based in Tokyo, Taiho is a Japanese pharmaceutical company that manufactures

and develops therapies for oncology, urology, and immunology. The

drug it is bringing to the United States, called S-1, has been used

for two years in Japan for advanced gastric cancer and for head and

neck cancer. It is in Phase 1 clinical trials in the United States

for advanced gastric cancer.

Kobayashi opened the U.S. office in Manhattan in 1997. The son of

a pharmaceutical executive, he went to Gakushuin University in Tokyo,

and worked at Japanese bank in New York before joining this pharmaceutical

firm eight years ago. This fall he and his wife, who have three young

children, moved to West Windsor from Rye, New York.

Top Of Page
Leaving Town

Quintiles Japan International Desk, 100 Overlook

Center, Princeton 08540.

Mikihiko Obayashi has closed the Princeton office of Quintiles Japan

International Desk, which interfaces with Japanese and American pharmaceutical

firms. Though business is being conducted from the company’s North

Carolina headquarters, some are working from home.

Top Of Page
Health Expansion

iPhysicianNet, 214 Carnegie Center, Suite 200,

Princeton 08540. Robert L. Maio, vice president, sales and service.

609-275-8818; fax, 609-275-8819. Home page: www.iPhysicianNet.com

The healthcare firm has expanded from 103 Carnegie Center to Carnegie

212, suite 200, but phone and fax are the same. Based in Scottsdale,

Arizona, it offers high quality interactive video detailing for selected

physicians (U.S. 1, May 22, 2002, and November 1, 2000). "Our

staff size in Princeton fluctuates according to whether we are hosting

a client’s call center," says Karen Metropulos, spokesperson.

The new office can accommodate call centers that might be needed.

Top Of Page
Expansions: CRO Clinphone

ClinPhone Inc., 9 Roszel Road, Princeton 08540.

Howard Goldberg, vice president. 609-524-4100; fax, 609-520-0633.

Home page: www.clinphone.com

ClinPhone has made its move from 2,100 feet at Princeton Commerce

Center on Emmons Drive to 6,200 square feet at 1009 Lenox Drive and

has a new phone and fax. It also opened a Chicago office and will

expand to the West Coast in the next few months.

Based in the United Kingdom, ClinPhone offers electronic trial management

services to support pharmaceutical and biotechnology companies during

the clinical research.

Top Of Page
New in Town CRO Esoterix

Esoterix, 20 Lake Drive, East Windsor 08520. Anthony

G. Busa, president of clinical trial center. 800-886-8992 or 609-443-2600;

fax, 512-225-1273. Home page: www.esoterix.com

Headed by Anthony G. Busa, a clinical trial center for

new drug testing opened in September in 32,000 square feet on Lake

Drive in East Windsor, in the Twin Rivers area. Based in Texas, this

company does the work of a laboratory testing company and a clinical

research organization. In fact, Busa most recently worked for Covance

at the Carnegie Center.

Founded in 1995, Esoterix has more than 600 employees in the United

States and Europe. It is privately funded through Manhattan-based

Behrman Capital, and shareholders invested an additional $5 million

earlier this year. Its net revenues increased by 18 percent last year

to $68.7 million.

Esoterix has three service areas: testing for office-based physicians

and oncologists, for hospitals (a variety of service including endocrinology

and toxicology tests), and for pharmaceuticals and biotech companies

(clinical trial services). In addition to its headquarters in Texas

and the new Lake Drive facility, it has operations in California,

Texas, Minnesota, Tennessee, Florida, and the Netherlands.

East Windsor’s center offers Phase 1 and Phase 2 testing in all six

of Esoterix’s disease areas and it coordinates with the company’s

new laboratory in Groningen, Netherlands. About 50 people are expected

to work here.

Busa has 25 years of experience in the pharmaceutical, medical and

contract research industries. A graduate of Iona College in New Rochelle,

New York, he most recently worked at Covance, where he was vice president

of corporate relations and vice president of corporate sales.

Top Of Page
Crosstown Moves

Atkins HF&G, 100 Canal Pointe Boulevard, Suite

212, Princeton 08540. Chris J. Taylor, chief operations officer. 609-514-0900;

fax, 609-514-9888. Home page: www.atkinsamericas.com

Following the merger of Hanscomb with Faithful & Gould, the Nassau

Street office of Faithful & Gould moved in with Hanscomb at 100 Canal

Pointe Boulevard in November, and it is now known as Atkins Hanscomb

Faithful & Gould. It does construction auditing, meaning that it acts

as a middleman between owners and contractors.

The parent company, Atkins, has 15,000 employees worldwide and is

traded on the London Stock Exchange. Atkins HF&G, the construction

auditing firm, has branches in 27 U.S. cities and 400 employees. About

28 people work in the Canal Pointe office, but dozens more are in

the field. The company expanded from 4,000 to 5,000 feet at Canal

Pointe, taking some of the space formerly occupied by Justballs.com

Top Of Page
Down-Sizing

Highlands Insurance Group (HIC), 275 Phillips Boulevard,

Ewing 08618. Stephen Kibblehouse, CEO. 609-896-1921. Home page:

www.highlandsinsurance.com

Late in November the property and casualty insurance company moved

from 1000 Lenox Drive to smaller quarters on Phillips Boulevard in

Ewing.

An article on November 6 incorrectly associated Highlands Insurance

Group with ARI Insurance Companies on Franklin Corner Road. ARI is

not connected with Highlands Insurance Group, American Reliance Group,

or Halliburton Company.

Top Of Page
Deaths

Rev. Robert A. Wieman, 79, on November 22 in a car accident.

An engineer who worked on the Manhattan Project he was a Presbyterian

minister.

Clifford A. Erickson, 77, on November 28. He was a chemist

for FMC Corp. and manager of information retrieval at Jacobus Pharmaceutical

Co.

Elizabeth Flemer, 47, on November 30. A singer and songwriter,

she taught English at Princeton Day School. A memorial service will

be Saturday, December 7, at 10:30 a.m. in Princeton University Chapel.

Anthony A. Dutton, 76, on December 1. He had been an electronics

technician at Princeton Plasma Physics Laboratory.

Henry S. Patterson II, 80, on December 1. He had been

president of Elizabethtown Water Company and mayor of Princeton Borough.

Eleanor B. Dearborn, 93, on December 2. She had been West

Windsor’s tax assessor.


Next Story


Corrections or additions?


This page is published by PrincetonInfo.com

— the web site for U.S. 1 Newspaper in Princeton, New Jersey.

Facebook Comments